[ARWR] YoY Quarter Result on 30-Sep-2012 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
28-Dec-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q4]
Profit Trend
QoQ- 33.51%
YoY- -91.36%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 44 44 44 44 290,848 181 203 -22.48%
PBT -24,741 -22,425 -13,805 -5,601 -2,947 -6,957,038 -19,308,392 -67.02%
Tax 2 5 354 -22,110,563 -14,078,360 -3,770 -15,848 -
NP -24,743 -22,430 -13,692 -5,314 -2,777 -2,004 -3,460 38.78%
Tax Rate - - - - - - - -
Total Cost 24,787 22,474 13,736 5,357 293,624 2,185 3,663 37.51%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -56,555.74 -51,269.58 -31,296.42 -12,145.56 -0.95 -1,109.12 -1,707.96 79.15%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.42 -0.42 -0.36 -0.38 -0.27 -0.28 -0.59 -5.50%
EPS Diluted -0.42 -0.41 -0.36 -0.38 -0.27 -0.28 -0.59 -5.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.